Market revenue in 2023 | USD 172.9 million |
Market revenue in 2030 | USD 337.3 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Tissue products |
Fastest growing segment | Immunosuppressive Drugs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunosuppressive Drugs, Tissue Products, Preservation Solutions |
Key market players worldwide | AbbVie Inc, Arthrex, Zimmer Biomet Holdings Inc, Medtronic PLC, Novartis AG ADR, Stryker Corp, BioLife Solutions Inc, Teva Pharmaceutical Industries Ltd, Asahi Kasei Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transplantation market will help companies and investors design strategic landscapes.
Tissue products was the largest segment with a revenue share of 56.91% in 2023. Horizon Databook has segmented the Saudi Arabia transplantation market based on immunosuppressive drugs, tissue products, preservation solutions covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in the number of transplantation procedures is a major factor driving the Saudi market. According to the Saudi Centre for Organ Transplantation, the number of transplant cases increased by 40% in 2015 as compared to 2014, with over 1,031 heart, lung, liver, & kidney transplant procedures conducted by Saudi government hospitals in 2015.
The increasing influx of foreign patients is most likely to accelerate the transplantation market in the country. In February 2018, the Ministry of Health and Prevention focused on National Program for Organ Transplantation.
The authorities aimed at driving UAE at the forefront of transplantation procedures both globally and locally, by regulating organ transplants to meet the global health standards. The regulation aims at preventing organ trafficking and streamlining the process of organ donation, preservation, transportation, & transplantation.
In 2016, the Arabian Gulf Medical Tourism Agency secured a 5- year plan to encourage medical tourists to seek treatment in its government and private hospitals. In July 2018, the Ministry of Health launched an awareness campaign to educate the community about the importance of organ donation. Such efforts by the government authorities are anticipated to create a demand in the country, thus propelling the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia transplantation market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia transplantation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account